News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,731 Results
Type
Article (88450)
Company Profile (813)
Press Release (788438)
Multimedia
Podcasts (222)
Webinars (34)
Section
Business (233445)
Career Advice (4155)
Deals (39930)
Drug Delivery (170)
Drug Development (91568)
Employer Resources (207)
FDA (18491)
Job Trends (17461)
News (398390)
Policy (40011)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (178)
Alliances (56986)
ALS (211)
Alzheimer's disease (1901)
Antibody-drug conjugate (ADC) (460)
Approvals (18747)
Artificial intelligence (766)
Autoimmune disease (266)
Automation (56)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (226)
Biotechnology (486)
Bladder cancer (191)
Brain cancer (77)
Breast cancer (747)
Cancer (5877)
Cardiovascular disease (514)
Career advice (3585)
Career pathing (48)
CAR-T (339)
CDC (73)
Celiac Disease (2)
Cell therapy (935)
Cervical cancer (45)
Clinical research (78060)
Collaboration (2178)
Company closure (7)
Compensation (1356)
Complete response letters (96)
COVID-19 (3020)
CRISPR (112)
C-suite (1110)
Cystic fibrosis (161)
Data (7512)
Decentralized trials (3)
Denatured (83)
Depression (179)
Dermatology (72)
Diabetes (602)
Diagnostics (7453)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (382)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (288)
Earnings (101420)
Editorial (73)
Employer branding (25)
Employer resources (174)
Events (136842)
Executive appointments (1130)
FDA (22178)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1785)
Gene editing (242)
Generative AI (85)
Gene therapy (767)
GLP-1 (1222)
Government (5523)
Grass and pollen (8)
Guidances (405)
Healthcare (21058)
HIV (84)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (333)
Immuno-oncology (97)
Indications (165)
Infectious disease (3386)
Inflammatory bowel disease (225)
Inflation Reduction Act (17)
Influenza (143)
Intellectual property (288)
Interviews (817)
IPO (17979)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (20)
Labor market (107)
Layoffs (672)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (31)
Lung cancer (784)
Lymphoma (422)
Machine learning (58)
Management (66)
Manufacturing (1061)
MASH (196)
Medical device (15178)
Medtech (15266)
Mergers & acquisitions (23153)
Metabolic disorders (1622)
mRNA (225)
Multiple sclerosis (188)
NASH (24)
Neurodegenerative disease (443)
Neuropsychiatric disorders (117)
Neuroscience (3473)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (793)
Opinion (360)
Ovarian cancer (203)
Pain (262)
Pancreatic cancer (281)
Parkinson's disease (377)
Partnered (39)
Patents (596)
Patient recruitment (652)
Peanut (65)
People (67547)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24117)
Phase 2 (33890)
Phase 3 (25500)
Pipeline (7727)
Policy (378)
Postmarket research (3556)
Preclinical (10846)
Press Release (72)
Prostate cancer (299)
Psychedelics (62)
Radiopharmaceuticals (343)
Rare diseases (1135)
Real estate (7449)
Recruiting (81)
Regulatory (29810)
Reports (75)
Research institute (2759)
Resumes & cover letters (653)
Rett syndrome (35)
RNA editing (24)
RSV (98)
Schizophrenia (182)
Series A (297)
Series B (219)
Service/supplier (30)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (53)
Startups (4351)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (136)
Vaccines (1244)
Venture capital (113)
Weight loss (545)
Women's health (121)
Worklife (24)
Date
Today (152)
Last 7 days (737)
Last 30 days (2708)
Last 365 days (33071)
2026 (10062)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (378)
Arkansas (16)
Asia (51954)
Australia (9132)
California (13064)
Canada (3709)
China (1379)
Colorado (565)
Connecticut (579)
Delaware (397)
Europe (119647)
Florida (1945)
Georgia (428)
Hawaii (4)
Idaho (69)
Illinois (1124)
India (94)
Indiana (615)
Iowa (24)
Japan (528)
Kansas (138)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1608)
Massachusetts (9559)
Michigan (397)
Minnesota (738)
Mississippi (7)
Missouri (158)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (91)
New Jersey (3510)
New Mexico (33)
New York (3456)
North Carolina (1777)
North Dakota (10)
Northern California (6385)
Ohio (404)
Oklahoma (26)
Oregon (55)
Pennsylvania (2612)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (84)
South Dakota (2)
Southern California (5101)
Tennessee (208)
Texas (2108)
United States (47009)
Utah (394)
Vermont (1)
Virginia (331)
Washington D.C. (88)
Washington State (1081)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
There are 877,731 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
April 20, 2026
·
10 min read
Press Releases
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
April 20, 2026
·
1 min read
Press Releases
Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor
April 20, 2026
·
3 min read
Press Releases
Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
April 20, 2026
·
5 min read
Press Releases
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
April 20, 2026
·
6 min read
Press Releases
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
April 20, 2026
·
11 min read
Press Releases
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
April 20, 2026
·
3 min read
Mergers & acquisitions
Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal
After entering the CAR T space in February, Eli Lilly is “jumping into in vivo CAR-T with both feet” with the acquisition of Kelonia Therapeutics and its gene delivery technology.
April 20, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026
April 20, 2026
·
8 min read
Press Releases
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
April 20, 2026
·
4 min read
1 of 87,774
Next
